US stocks pause near record highs as S&P 500, Nasdaq, and Dow futures steady ahead of key GDP data shaping today’s stock market forecast.
U.S. stock futures are treading water Tuesday, with traders taking a breath after the S&P 500 logged a three-day win streak. It’s a quiet start to a holiday-shortened week, but don’t confuse quiet with complacent. With GDP on deck, positioning feels light and deliberate. Nobody’s in a rush to press bets before the data hits.
Futures tied to the Dow dipped modestly, while S&P 500 and Nasdaq 100 futures hovered just below flat. That follows a solid prior session where the S&P 500 climbed again, helped by strength in semiconductors and broad sector participation. Ten of eleven sectors closed higher, a healthy look on the surface, even if volume stayed thin.
Materials and financials led the charge in the prior session, a signal traders haven’t ignored. Gains in Newmont and Freeport-McMoRan tracked record highs in gold and silver, while bank stocks continued to attract steady flows. That rotation matters. It supports the idea this isn’t just a narrow tech trade, even if megacaps still do the heavy lifting.
Chipmakers also did their part. Nvidia jumped 1.5%, with Micron and Oracle adding fuel. The market still likes the AI story, but the tone has shifted from chasing to selectively adding. According to Chris Harvey of CIBC Capital Markets, valuations don’t yet show the excess seen in the late 1990s, and leadership from financials reinforces that view.
Treasury yields eased ahead of the data, with the 10-year slipping toward 4.14% and the 2-year just under 3.50%. That pullback suggests rates traders aren’t leaning aggressively one way or the other. GDP is the hinge. A firm number keeps the growth story alive without forcing a rethink on inflation. A softer read could invite more duration buying.
The GDP report, delayed by the government shutdown, is expected to show solid third-quarter growth. That strength has been driven by resilient consumer spending and heavy corporate investment in AI. The market respects that backdrop, even if some desks wonder how repeatable it is into next year.
Single-name action is doing some of the talking. Tesla caught a bid after Canaccord Genuity raised its price target, signaling confidence beyond near-term demand softness.
Novo Nordisk jumped premarket after FDA approval for its oral GLP-1 treatment, keeping healthcare firmly on traders’ radar.
With early closes and holiday liquidity, follow-through may be limited. Still, GDP can reset expectations quickly. If growth holds up, buyers likely stay engaged, just not reckless. If it disappoints, caution creeps back in fast. Bottom line: the market wants to stay constructive, but it needs the data to cooperate.
More Information in our Economic Calendar.
James Hyerczyk is a U.S. based seasoned technical analyst and educator with over 40 years of experience in market analysis and trading, specializing in chart patterns and price movement. He is the author of two books on technical analysis and has a background in both futures and stock markets.